Posaconazole: An Update of Its Clinical Use
Posaconazole (PCZ) is a relatively new addition to the azole antifungals. It has fungicidal activities against Aspergillus fumigatus, Blastomyces dermatitidis, selected Candida species, Crytopcoccus neoformans, and Trichosporon. PCZ also has fungistatic activities against Candida, Coccidioides, sele...
Saved in:
Main Authors: | Simon Leung (Author), Mara N. Poulakos (Author), Jade Machin (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014) -
Formation and Characterisation of Posaconazole Hydrate Form
by: Michail Lykouras, et al.
Published: (2022) -
Management of rhinomaxillary mucormycosis with Posaconazole in immunocompetent patients
by: Sachin Rai, et al.
Published: (2016) -
A Review of Population Pharmacokinetic Models of Posaconazole
by: Ding Q, et al.
Published: (2022) -
Posaconazole in the management of refractory invasive fungal infections
by: Stefan Langner, et al.
Published: (2008)